BioNet News 01 Apr 2024 BioNet presents at the World Vaccine Congress in Washington 2024 Join BioNet at the World Vaccine Congress 2024 April 1st-4th in Washington D.C. The WVC is the largest and most… Supachai
BioNet News 12 Mar 2024 BioNet Announces New Scientific Advisory Board Member Dr. William Gruber We are pleased to announce the appointment of Dr. William Gruber as our new Scientific Advisory Board Member. Dr William… Supachai
BioNet News 07 Mar 2024 BioNet presents at the INMIS 2024 in San Jose, Costa Rica BioNet is pleased to announce its participation in the 6th annual International Neonatology and Maternal Immunization Symposium (INMIS 2024), taking… Supachai
BioNet News 07 Mar 2024 BioNet Announces New Scientific Advisory Board Member Prof. Peter Openshaw We are pleased to announce the appointment of Prof. Peter Openshaw as our new Scientific Advisory Board Member. Peter Openshaw… Supachai
BioNet News 06 Mar 2024 BioNet Announces New Scientific Advisory Board Member Dr. Norbert Pardi We are pleased to announce the appointment of Dr. Norbert Pardi as our new Scientific Advisory Board Member. Dr Norbert… Supachai
BioNet News 12 Dec 2023 Effective and safe transfer of maternal antibodies persisting two months postpartum following maternal immunization with different doses of recombinant pertussis-containing vaccines Highlights • Recombinant pertussis vaccine is safe for both mother and newborn. • There is effective transplacental antibody transfer to… Supachai
BioNet News 22 Jun 2023 A phase 2 randomized controlled dose-ranging trial of recombinant pertussis booster vaccines containing genetically inactivated pertussis toxin in pregnant women Highlights • Recombinant acellular pertussis vaccine is safe and immunogenic in pregnant women. • Vaccine formulations containing PTgen were non-inferior… Supachai
BioNet News 13 Feb 2023 Produire des médicaments et des vaccins en Occitanie : un ambitieux projet porté à Toulouse Et si on produisait bientôt des médicaments et des vaccins en Occitanie ? Le CHU de Toulouse et ses partenaires… Supachai
BioNet News, Press Releases 17 Dec 2022 Pharmaniaga and BioNet Sign Research Collaboration Agreement for Children’s Hexavalent Vaccine KUALA LUMPUR, 13 DECEMBER 2022 – Pharmaniaga LifeScience Sdn Bhd (PLS), a wholly-owned subsidiary of Malaysia's leading pharmaceutical company, Pharmaniaga… Supachai
BioNet News, Press Releases 08 Dec 2022 INFECTIOUS AND EMERGING DISEASES: A BIOCLUSTER PROJECT IN OCCITANIA Toulouse, Lyon and Bangkok, 8th December 2022 - Within the framework of the "BIOCLUSTER" Call for Expressions of Interest of… Supachai